Recent progress on the molecular aspects of endocrine tumors : clinical implications, 39es Journées Internationales Henri-Pierre Klotz d'Endocrinologie Clinique, Paris, 30-31 mai 1996 39th International Henri-Piere Klotz Symposium on Clinical Endocrinology, Paris, May 30-31, 1996
著者
書誌事項
Recent progress on the molecular aspects of endocrine tumors : clinical implications, 39es Journées Internationales Henri-Pierre Klotz d'Endocrinologie Clinique, Paris, 30-31 mai 1996 = 39th International Henri-Piere Klotz Symposium on Clinical Endocrinology, Paris, May 30-31, 1996
（Hormone research, v. 47,
Karger, 1997
大学図書館所蔵 件 / 全3件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographical references and index
内容説明・目次
内容説明
Presents the proceedings of the 39th International Henri-Pierre Klotz Symposium on Hormone Binding Proteins, held in Paris, May 1996. The text focuses on the clinical applications of recent progress on the molecular aspects of endocrine tumours.
目次
- Targeted oncogenesis in the thyroid of transgenic mice, J. Feunteun et al
- protein kinase C alpha and tumorigenesis of the endocrine gland, C. Prevostel et al
- origin and progression of thyroid epithelial tumors - cellular and molecular mechanisms, D. Wynford-Thomas
- clinical consequences of activating germline mutations of TSH receptor, the concept of toxic hyperplasia, J. Leclere et al
- targetting medullary thyroid carcinomas with bispecific antibodies and bivalent haptens, E. Rouvier et al
- RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma, D.J. Marsh et al
- multiple endocrine neoplasia type 1 and the search for the genetic trigger, F. Farnebo et al
- tumor suppressor genes in the pathogenesis of human pituitary tumors, R.N. Clayton et al
- molecular mechansism of parathyroid hyperplasia and neoplasia, M.L. Brandi
- genetic testing in presymptomatic diagnosis of multiple endocrine neoplasia, A. Calender et al
- management of patients and subjects at risk for multiple endocrine neoplasia type 1 - MEN 1, P. Chanson et al
- multiple endocrine neoplasia type 2 - management of patients and subjects at risk, B. Conte-Devolx et al
- abnormal transduction mechanisms in pituitary adenomas, A. Barlier et al
- cyclic AMP and calcium in the transduction of hypothalamic neurohormone action in human pituitary tumors, A. Spada et al
- nerve growth factor suppresses the tumoral phenotype of human prolactinomas, C. Missale et al
- effects of the cAMP pathway activation in somatotrophs, J. Bertherat
- pit-1 gene expression in human pituitary adenomas, I. Pellegrini-Bouiller et al
- V3 vasopressin receptor and corticotropic phenotype in pituitary and nonpituitary tumors, Y. de Keyzer et al
- genetic alterations of the RET proto-oncogene in familial and sporadic phenochromocytomas, P. Rodien et al
- molecular markers for malignancy in andrenocortical tumors, C. Gicquel and Y. LeBouc
- adrenocorticotropin receptor and adrenal disorders, B. Allolio and M. Reincke
- adrenal incidentaloma - an overview of clinical and epidemiological data from the National Italian Study Group, A. Angeli et al
- adrenal incidentaloma - an overview of hormonal data from the National Italian Study Group, F. Mantero et al.
「Nielsen BookData」 より
